한글목차

세계 샤가스병(Chagas disease) 시장을 조사했으며, 시장 개요, 시장 영향요인 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 신약 동향, 경쟁 구도, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 요약 및 하이라이트

제3장 시장 개요

• 역사
• Trypanosoma Cruzi
• Vector and T. cruzi
• Transmission Routes
• Clinical Forms
• 향후 전망
• 신약

제4장 샤가스병 : 약제별

• 개요
• Benznidazole
• Benznidazole의 독성
• Nifurtimox
• Nifurtimox의 독성

제5장 샤가스병 : 진단별

• 개요
• 혈청학(항체 탐지)
• 분자 검사

제6장 경쟁 구도

• 경쟁 분석

제7장 기업 개요

• BAYER AG
• INSUD PHARMA

제8장 부록 : 두자어

영문목차

Highlights:

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Report Scope:

The current research provides a thorough overview of the CD market. This report analyzes CD market trends with epidemiological and regional markets, highlights the current market and offers a detailed competitive environment analysis. The scope of this report covers treatment throughout Latin America.

Report Includes:

• An overview of the global chagas disease (T. cruzi infection) market
• Analyses of the global market trends, with historical market revenue from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the market size and revenue forecast for global chagas disease market, and corresponding market share analysis based on the product type, treatment, and region
• Overview of the significant driving trends and challenges that affect the global market and its vendor landscape
• Review of the epidemiology of chagas disease and potential of key marketed drugs and recent approvals
• Discussion of sustainability trends and factors in the chagas disease market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, case study, and the ESG practices followed
• Analysis of the competitive intelligence based on recent developments, key financials and segmental revenues, and product launch strategies
• Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses

Table of Contents

Chapter 1 Introduction

• Overview
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Segmentation Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

• History
• Trypanosoma Cruzi
• Vector and T. cruzi
• Transmission Routes
• Clinical Forms
• Future Perspectives
• Novel Drugs

Chapter 4 Chagas Disease by Drugs

• Overview
• Benznidazole
• Toxicity of Benznidazole
• Nifurtimox
• Toxicity of Nifurtimox

Chapter 5 Chagas Disease by Diagnosis

• Overview
• Serology (Antibody Detection)
• Molecular Testing

Chapter 6 Competitive Landscape

• Competitive Analysis

Chapter 7 Company Profiles

• BAYER AG
• INSUD PHARMA

Chapter 8 Appendix: Acronyms